Aura Biosciences Inc (NASDAQ:AURA) price on Thursday, July 03, rose 1.55% above its previous day’s close as an upside momentum from buyers pushed the stock’s value to $6.56.
A look at the stock’s price movement, the close in the last trading session was $6.46, moving within a range at $6.3 and $6.72. The beta value (5-Year monthly) was 0.423. Turning to its 52-week performance, $12.38 and $4.34 were the 52-week high and 52-week low respectively. Overall, AURA moved 3.63% over the past month.
Aura Biosciences Inc’s market cap currently stands at around $406.75 million, with investors looking forward to this quarter’s earnings report slated for on 2025-May-15.
Turning to the stock’s technical picture we see that short term indicators suggest on average that AURA is a 25% Buy. On the other hand, the stock is on average a 50% Sell as suggested by medium term indicators while long term indicators are putting the stock in 50% Sell category.
1 analyst(s) have given their forecast ratings for the stock on a scale of 1.00-5.00 for a strong buy to strong sell recommendation. A total of 0 analyst(s) rate the stock as a Hold, 1 recommend AURA as a Buy and 0 give it an Overweight rating. Meanwhile, 0 analyst(s) rate the stock as Underweight and 0 say it is a Sell. As such, the average rating for the stock is Buy which could provide an opportunity for investors keen on increasing their holdings of the company’s stock.
AURA’s current price about 2.76% and 9.44% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 57.25, while 7-day volatility ratio is 5.98% and 6.35% in the 30-day chart. Further, Aura Biosciences Inc (AURA) has a beta value of 0.45. Analysts have given the company’s stock an average 52-week price target of $22, forecast between a low of $19 and high of $25. Looking at the price targets, the low is -189.63% off current price level while to achieve the yearly target high, price needs to move -281.1%. Nonetheless, investors will most likely welcome a -235.37% jump to $22 which is the analysts’ median price.
If we refocus on Aura Biosciences Inc (NASDAQ:AURA), historical trading data shows that trading volumes averaged 0.29 over the past 10 days and 237.89K over the past 3 months. The company’s latest data on shares outstanding shows there are 50.23 million shares.
The 24.96% of Aura Biosciences Inc’s shares are in the hands of company insiders while institutional holders own 61.09% of the company’s shares. Also important is the data on short interest which shows that short shares stood at 2.72 million on 2025-06-13, giving us a short ratio of 11.35. The data shows that as of 2025-06-13 short interest in Aura Biosciences Inc (AURA) stood at 500.0 of shares outstanding, with shares short rising to 2.39 million registered in 2025-05-15. Current price change has pushed the stock -10.99% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the AURA stock continues to rise going into the next quarter.
